National Institute of Allergy and Infectious Diseases; Notice of Meetings, 79038-79039 [2016-27139]
Download as PDF
<![CDATA[
asabaliauskas on DSK3SPTVN1PROD with NOTICES
79038
Federal Register / Vol. 81, No. 218 / Thursday, November 10, 2016 / Notices
Name of Committee: National Advisory
Allergy and Infectious Diseases Council.
Date: September 11, 2017.
Open: 10:30 a.m. to 11:40 a.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Closed: 11:40 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council,
Acquired Immunodeficiency Syndrome
Subcommittee.
Date: September 11, 2017.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Room A, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Program advisory discussions and
reports from division staff.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee:National Advisory
Allergy and Infectious Diseases Council
Allergy, Immunology and Transplantation
Subcommittee.
Date:September 11, 2017.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council,
Microbiology and Infectious Diseases
Subcommittee.
Date: September 11, 2017.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:46 Nov 09, 2016
Jkt 241001
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.niaid.nih.gov/facts/facts.htm, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Date: November 16, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Brian Hoshaw, Ph.D.,
Scientific Review Officer, National Eye
Institute, National Institutes of Health,
Division of Extramural Research, 5635
Fishers Lane, Suite 1300, Rockville, MD
20892, 301–451–2020, hoshawb@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: November 4, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institute of Allergy and
Infectious Diseases; Notice of
Meetings
[FR Doc. 2016–27138 Filed 11–9–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel, NEI R21 Secondary
Data Analysis and R13 Conference Grant
Applications.
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Dated: November 4, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–27136 Filed 11–9–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the AIDS
Research Advisory Committee, NIAID.
The meetings will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: January 30, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building Conference Rooms E1/E2
45 Center Drive, Bethesda, MD 20892
Contact Person: Mark A. Mueller,
Executive Secretary, AIDS Research Advisory
Committee Division of AIDS, NIAID/NIH,
5601 Fishers Lane, RM 8D39, Bethesda, MD
20892, 301–402–2308, mark.mueller@
nih.gov.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: June 5, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Reports from the Division Director
and other staff.
E:\FR\FM\10NON1.SGM
10NON1
Federal Register / Vol. 81, No. 218 / Thursday, November 10, 2016 / Notices
Place: National Institutes of Health,
Natcher Building Conference Rooms E1/E2
45 Center Drive, Bethesda, MD 20892.
Contact Person: Mark A. Mueller,
Executive Secretary, AIDS Research Advisory
Committee Division of AIDS, NIAID/NIH,
5601 Fishers Lane, RM 8D39, Bethesda, MD
20892, 301–402–2308, mark.mueller@
nih.gov.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: September 11, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building Conference Rooms E1/E2
45 Center Drive, Bethesda, MD 20892.
Contact Person: Mark A. Mueller,
Executive Secretary, AIDS Research Advisory
Committee Division of AIDS, NIAID/NIH,
5601 Fishers Lane, RM 8D39, Bethesda, MD
20892, 301–402–2308, mark.mueller@
nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 4, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Improved Technologies and Ligands for NonInvasive Brain Imaging (R41/R42).
Date: November 29, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, NIH, DHHS, 6001
Executive Blvd., Room 4238, MSC 9550,
Bethesda, MD 20892–9550, 301–827–5819,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, R13
Conference Grant Review.
Date: December 1, 2016.
Time: 10:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4238, MSC 9550, Bethesda, MD 20892, (301)
827–5820, hiromi.ono@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
[FR Doc. 2016–27139 Filed 11–9–16; 8:45 am]
Dated: November 4, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2016–27142 Filed 11–9–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
asabaliauskas on DSK3SPTVN1PROD with NOTICES
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
17:46 Nov 09, 2016
Jkt 241001
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
79039
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Clinical Trial
Implementation Grant (R01).
Date: November 29, 2016.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Chelsea D. Boyd, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 5601
Fishers Lane, MSC–9823, Rockville, MD
20852–9834, 240–669–2081, chelsea.boyd@
nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Clinical Trial
Implementation Cooperative Agreement
(U01).
Date: December 5, 2016.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Chelsea D. Boyd, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 5601
Fishers Lane, MSC–9823, Rockville, MD
20852–9834, 240–669–2081, chelsea.boyd@
nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Peer Review Meeting.
Date: December 7–9, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Jane K. Battles, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 5601
Fishers Lane, Room 3F30B, Rockville, MD
20852, 240–669–5029, battlesja@
mail.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Investigator Initiated
Program Project Applications (P01).
Date: December 7, 2016.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Raymond R. Schleef,
Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3E61, National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
(240) 669–5019, schleefrr@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Peer Review Meeting.
E:\FR\FM\10NON1.SGM
10NON1
]]>Agencies
[Federal Register Volume 81, Number 218 (Thursday, November 10, 2016)]
[Notices]
[Pages 79038-79039]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-27139]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meetings
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of meetings of the AIDS
Research Advisory Committee, NIAID.
The meetings will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: AIDS Research Advisory Committee, NIAID.
Date: January 30, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Reports from the Division Director and other staff.
Place: National Institutes of Health, Natcher Building
Conference Rooms E1/E2 45 Center Drive, Bethesda, MD 20892
Contact Person: Mark A. Mueller, Executive Secretary, AIDS
Research Advisory Committee Division of AIDS, NIAID/NIH, 5601
Fishers Lane, RM 8D39, Bethesda, MD 20892, 301-402-2308,
mark.mueller@nih.gov.
Name of Committee: AIDS Research Advisory Committee, NIAID.
Date: June 5, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Reports from the Division Director and other staff.
[[Page 79039]]
Place: National Institutes of Health, Natcher Building
Conference Rooms E1/E2 45 Center Drive, Bethesda, MD 20892.
Contact Person: Mark A. Mueller, Executive Secretary, AIDS
Research Advisory Committee Division of AIDS, NIAID/NIH, 5601
Fishers Lane, RM 8D39, Bethesda, MD 20892, 301-402-2308,
mark.mueller@nih.gov.
Name of Committee: AIDS Research Advisory Committee, NIAID.
Date: September 11, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Reports from the Division Director and other staff.
Place: National Institutes of Health, Natcher Building
Conference Rooms E1/E2 45 Center Drive, Bethesda, MD 20892.
Contact Person: Mark A. Mueller, Executive Secretary, AIDS
Research Advisory Committee Division of AIDS, NIAID/NIH, 5601
Fishers Lane, RM 8D39, Bethesda, MD 20892, 301-402-2308,
mark.mueller@nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 4, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-27139 Filed 11-9-16; 8:45 am]
BILLING CODE 4140-01-P
